Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review

<b>Table S1:</b> Nanostructured biomolecules approved or in clinical trials for cancer therapy [8].<b>Table S2: </b>examples of pH-responsive medication delivery systems.<b>Table S3.</b> Nanocarriers that respond to enzymes for cancer theragnostic.<b>Table S4.</b> Nanocarriers with redox response for cancer theranostics [108].<b>Table S5:</b> Representative hypoxia-responsive nanocarriers [108].<b>Table S6: </b>Drug release effects of various types of hypoxia-sensitive NPs.